Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-12-22

Clinical Trial Update: The Efficacy and Safety of Liraglutide Compared to Sitagliptin, Both in Combination With Metformin in Chinese Subjects With Type 2 Diabetes [Phase 4]

View source ↗

Summary

A Phase 4 trial in Chinese adults with Type 2 diabetes comparing liraglutide plus metformin to sitagliptin plus metformin to evaluate relative efficacy and safe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sitagliptin (sitagliptin)
  • liraglutide (liraglutide)
  • metformin (metformin)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED | Results posted: 2015-12-22